Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial

R. Van Dijck; B. van der Holt; A. E. C. Broers; M. D. Hazenberg; T. Devos; M. W. M. van der Poel; D. Breems; L. Deleu; B. A. G. Schuthof; C. M. C. van Hooije; J. J. Cornelissen; N. P. M. Schaap; P. A. W. te Boekhorst

doi:10.1038/s41409-026-02900-6

Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial

R. Van Dijck^*
, B. van der Holt
, A. E. C. Broers
, M. D. Hazenberg
, T. Devos
, M. W. M. van der Poel
, D. Breems
, L. Deleu
, B. A. G. Schuthof
, C. M. C. van Hooije
, J. J. Cornelissen
, N. P. M. Schaap
, P. A. W. te Boekhorst

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum › Academic

Abstract

Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-026-02841-0, published online 18 March 2026 In this article the author name ‘B.A.G. Schuthof’ was incorrectly written as ‘B. Schuthof’. The original article has been corrected.

Original language	English
Pages (from-to)	783
Number of pages	1
Journal	Bone Marrow Transplantation
Volume	61
Issue number	6
DOIs	https://doi.org/10.1038/s41409-026-02900-6
Publication status	Published - Jun 2026

Access to Document

10.1038/s41409-026-02900-6Licence: CC BY-NC-ND

1 Comment/Letter to the editor

Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial
Van Dijck, R., van der Holt, B., Broers, A. E. C., Hazenberg, M. D., Devos, T., van der Poel, M. W. M., Breems, D., Deleu, L., Schuthof, B., van Hooije, C. M. C., Cornelissen, J. J., Schaap, N. P. M. & te Boekhorst, P. A. W., Jun 2026, In: Bone Marrow Transplantation. 61, 6, p. 747-749 3 p.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Open Access

Cite this

Van Dijck, R., van der Holt, B., Broers, A. E. C., Hazenberg, M. D., Devos, T., van der Poel, M. W. M., Breems, D., Deleu, L., Schuthof, B. A. G., van Hooije, C. M. C., Cornelissen, J. J., Schaap, N. P. M., & te Boekhorst, P. A. W. (2026). Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial. Bone Marrow Transplantation, 61(6), 783. https://doi.org/10.1038/s41409-026-02900-6

@article{cfc197b4279d427ca1ac83c983c1b42d,

title = "Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial",

abstract = "Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-026-02841-0, published online 18 March 2026 In this article the author name {\textquoteleft}B.A.G. Schuthof{\textquoteright} was incorrectly written as {\textquoteleft}B. Schuthof{\textquoteright}. The original article has been corrected.",

author = "\{Van Dijck\}, R. and \{van der Holt\}, B. and Broers, \{A. E. C.\} and Hazenberg, \{M. D.\} and T. Devos and \{van der Poel\}, \{M. W. M.\} and D. Breems and L. Deleu and Schuthof, \{B. A. G.\} and \{van Hooije\}, \{C. M. C.\} and Cornelissen, \{J. J.\} and Schaap, \{N. P. M.\} and \{te Boekhorst\}, \{P. A. W.\}",

year = "2026",

month = jun,

doi = "10.1038/s41409-026-02900-6",

language = "English",

volume = "61",

pages = "783",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer",

number = "6",

}

Van Dijck, R, van der Holt, B, Broers, AEC, Hazenberg, MD, Devos, T, van der Poel, MWM, Breems, D, Deleu, L, Schuthof, BAG, van Hooije, CMC, Cornelissen, JJ, Schaap, NPM & te Boekhorst, PAW 2026, 'Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial', Bone Marrow Transplantation, vol. 61, no. 6, pp. 783. https://doi.org/10.1038/s41409-026-02900-6

TY - JOUR

T1 - Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial

AU - Van Dijck, R.

AU - van der Holt, B.

AU - Broers, A. E. C.

AU - Hazenberg, M. D.

AU - Devos, T.

AU - van der Poel, M. W. M.

AU - Breems, D.

AU - Deleu, L.

AU - Schuthof, B. A. G.

AU - van Hooije, C. M. C.

AU - Cornelissen, J. J.

AU - Schaap, N. P. M.

AU - te Boekhorst, P. A. W.

PY - 2026/6

Y1 - 2026/6

N2 - Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-026-02841-0, published online 18 March 2026 In this article the author name ‘B.A.G. Schuthof’ was incorrectly written as ‘B. Schuthof’. The original article has been corrected.

AB - Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-026-02841-0, published online 18 March 2026 In this article the author name ‘B.A.G. Schuthof’ was incorrectly written as ‘B. Schuthof’. The original article has been corrected.

U2 - 10.1038/s41409-026-02900-6

DO - 10.1038/s41409-026-02900-6

M3 - Erratum / corrigendum

SN - 0268-3369

VL - 61

SP - 783

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 6

ER -

Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial

Abstract

Access to Document

Fingerprint

Research output

Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial

Cite this